Purpose: The intent of this article is to evaluate a novel approach, using rapid cycle analytics and real world evidence, to optimize and improve the medication evaluation process to help the formulary decision making process, while reducing time for clinicians. Summary: The Pharmacy and Therapeutics (P&T) Committee within each health system is responsible for evaluating medication requests for formulary addition. Members of the pharmacy staff prepare the drug monograph or a medication use evaluation (MUE) and allocate precious clinical resources to review patient charts to assess efficacy and value. We explored a novel approach to evaluate the value of our intravenous acetaminophen (IV APAP) formulary admittance. This new methodology, called rapid cycle analytics, can assist hospitals in meeting and/or exceeding the minimum criteria of formulary maintenance as defined by the Joint Commission Standards. In this particular study, we assessed the effectiveness of IV APAP in total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures. We assessed the correlation to same-stay opioid utilization, average length of inpatient stay and post anesthesia care unit (PACU) time. Conclusion: We were able to explore and improve our organization’s approach in evaluating medications by partnering with an external analytics expert to help organize and normalize our data in a more robust, yet time efficient manner. Additionally, we were able to use a significantly larger external data set as a point of reference. Being able to perform this detailed analytical exercise for thousands of encounters internally and using a data warehouse of over 130 million patients as a point of reference in a short time has improved the depth of our assessment, as well as reducing valuable clinical resources allocated to MUEs to allow for more direct patient care. This clinically real-world and data-rich analytics model is the necessary foundation for using Artificial or Augmented Intelligence (AI) to make real-time formulary and drug selection decisions
PerssonELMillerKSNiemanJA, et al. Formulary evaluation using a class review approach: experience and results from an academic medical center. Pharmacy and Therapeutics. 2013;38(4):213-216.
2.
StokesLBRogersJWHertigJBWeberRJ.Big data: implications for health system pharmacy. Hosp Pharm. 2016;51(7):599-603.
3.
Cadence Pharmaceuticals Inc. OFIRMEV (Acetaminophen) Injection [Prescribing Information]. San Diego, CA: Cadence Pharmaceuticals Inc; 2010.
4.
SinglaNKParulanCSamsonR, et al. Plasma and cerebrospinal fluid pharmacokinetic parameters after single-dose administration of intravenous, oral, or rectal acetaminophen. Pain Pract. 2012;12(7):523-532.
5.
NishimotoRN.OFIRMEV: an old drug becomes new again. Anesth Prog. 2014;61(3):99-102.
6.
Murata- OoiwaMTsukadaSWakuiM. Intravenous acetaminophen in multimodal pain management for patients undergoing total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Arthroplasty. 2017;32(10):3024-3028.
7.
SinatraRSJahrJSReynoldsLWViscusiERGroudineSBPayen-ChampenoisC.Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology. 2005;102(4):822-831.
8.
RemyCMarretEBonnetF.Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth. 2005;94(4):505-513.
9.
HuangPSGleasonSMShahJABurosAFHoffmanDA.Efficacy of intravenous acetaminophen for postoperative analgesia in primary total knee arthroplasty. J Arthroplasty. 2018;33:1052-1056.
10.
KellyJSOpshaYCostelloJSchillerDHolaET.Opioid use in knee arthroplasty after receiving intravenous acetaminophen. Pharmacotherapy. 2014;34:22s-26s.
11.
RaiffDVaughanCMcGeeA. Impact of intraoperative acetaminophen administration on postoperative opioid consumption in patients undergoing hip or knee replacement. Hosp Pharm. 2014;49:1022-1032.
12.
NwagbologuNSarangarmPD’AngioR.Effect of intravenous acetaminophen on postoperative opioid consumption in adult orthopedic surgery patients. Hosp Pharm. 2016;51:730-737.
13.
O’NealJBFreibergAAYelleMD, et al. Intravenous vs oral acetaminophen as an adjunct to multimodal analgesia after total knee arthroplasty: a prospective, randomized, double-blind clinical trial. J Arthroplasty. 2017;32(10):3029-3033.
14.
PolitiJRDavisRLIIMatrkaAK. Randomized prospective trial comparing the use of intravenous versus oral acetaminophen in total joint arthroplasty. J Arthoplasty. 2017;32(4):1125-1127.
15.
HickmanSRMathiesonKMBradfordLMGarmanCDGreggRWLukensDW.Randomized trial of oral versus intravenous acetaminophen for postoperative pain control. Am J Health Syst Pharm. 2018;75(6):367-375.
